[Corrigendum] miR‑181a‑5p inhibits the proliferation and invasion of drug‑resistant glioblastoma cells by targeting F‑box protein 11 expression
Xueyan Wen, Songrong Li, Mengchan Guo, Hongzhan Liao, Yongmin Chen, Xi Kuang, Xiaoping Liao, Lin Ma, Qifu Li
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCircular RNAs in diseases
Oncol Lett 20: 235, 2020; DOI: 10.3892/ol.2020.12098
Following the publication of the above article, an interested reader drew to the authors’ attention that the western blot data (both the control GAPDH and the FBXO11 protein bands) in Fig. 3C on p. 6 were strikingly similar to data which had previously appeared in an article published in the journal Oncotarget, albeit one of the authors (Hongzhan Liao) was featured as an author on both papers. After having re-examined their original data, the authors realized that the wrong data had inadvertently been included in this figure part.
The revised version of Fig. 4, now featuring the correct data for the GAPDH and the FBXO11 experiments in Fig. 3C, is shown on the next page. Note that the errors made in assembling this figure did not affect the overall conclusions reported in the paper. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Oncology Letters for allowing them the opportunity to publish this. The authors also apologize to the readership for any inconvenience caused.